Inactive Instrument

All News Theradiag

Equities

Biosynex: merger with Theradiag completed	12-18	CF
Q-linea signs distribution partnership for Benelux	11-17	AQ
Theradiag SA Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23	CI
Theradiag: improved first-half profitability	18/09/23	CF
Theradiag: 7% growth in half-year sales	17/07/23	CF
Theradiag SA Reports Audited Revenue Results for the Second Quarter and First Half Ended on June 30, 2023	17/07/23	CI
Theradiag SA Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Theradiag SA Announces Executive Changes	01/03/23	CI
Theradiag SA Announces Management Changes	01/03/23	CI
Biosynex SA completed the acquisition of additional 46.52% stake in Theradiag SA for €21.6 million.	30/01/23	CI
Biosynex: takeover bid reopened for Theradiag shares	18/01/23	CF
Theradiag: takeover bid reopened on January 18	17/01/23	CF
Theradiag: 2022 sales without surprises	16/01/23	CF
Biosynex: successful takeover bid for Theradiag	16/01/23	CF
Theradiag: over 2.8 million shares tendered to the takeover bid	16/01/23	CF
Theradiag : Inside Information / News release on accounts, results	16/01/23	PU
Theradiag: growth of nearly 10% in 2022	16/01/23	CF
Theradiag SA Announces Revenue Results for the Year Ended December 31, 2022	16/01/23	CI
Biosynex SA completed the acquisition of 40% stakes in Theradiag SA.	11/01/23	CI
Theradiag : Inside Information / Other news releases	06/01/23	PU

No results for this search